Patents-Review.com
ClassID:

170652 ⎘

G01N2333/926 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on glycosyl compounds (3.2) acting on alpha -1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase

Sub-classes:
Recent Application in this class:
#1
20250197836
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #2
20250197835
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #3
20250197834
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #4
20250197833
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #5
20250197832
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #6
20250172545
2025-05-29

METHOD FOR EXTRACTING AND IDENTIFYING POLYSACCHARIDE FROM COMPLEX SAMPLE

 #7
20250154592
2025-05-15

Methods and Compositions for Evaluating Biomarkers in Salivary Exosomes and Evaluating Cognitive Fatigue

 #8
20250154488
2025-05-15

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #9
20250051747
2025-02-13

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #10
20240318158
2024-09-26

PH20 polypeptide variants, formulations and uses thereof

 #11
20240209337
2024-06-27

PH20 polypeptide variants, formulations and uses thereof

 #12
20240201166
2024-06-20

DIAGNOSIS AND TREATMENT OF CONGESTIVE COLON FAILURE (CCF)

 #13
20240192188
2024-06-13

METHOD OF AND AN APPARATUS FOR DETERMINING DIETARY FIBER AND A SAMPLE CONTAINER SYSTEM FOR USE THEREIN

 #14
20240168035
2024-05-23

METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION

 #15
20240026328
2024-01-25

PH20 polypeptide variants, formulations and uses thereof

 #16
20240026327
2024-01-25

PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

 #17
20240011008
2024-01-11

PH20 polypeptide variants, formulations and uses thereof

 #18
20240002826
2024-01-04

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #19
20240002825
2024-01-04

PH20 polypeptide variants, formulations and uses thereof

 #20
20230357739
2023-11-09

PH20 polypeptide variants, formulations and uses thereof

 #21
20230295593
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

 #22
20230295592
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

 #23
20230287381
2023-09-14

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #24
20230250409
2023-08-10

PH20 polypeptide variants, formulations and uses thereof

 #25
20230212547
2023-07-06

PH20 polypeptide variants, formulations and uses thereof

 #26
20230151346
2023-05-18

PH20 polypeptide variants, formulations and uses thereof

 #27
20220323826
2022-10-13

System, apparatus and method for training a subject

 #28
20210284985
2021-09-16

PH20 polypeptide variants, formulations and uses thereof

 #29
20210277376
2021-09-09

PH20 polypeptide variants, formulations and uses thereof

 #30
20210046148
2021-02-18

Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis

 #31
20200386768
2020-12-10

Methods for quantifying drug concentration in a prodrug composition

 #32
20200318091
2020-10-08

PH20 polypeptide variants, formulations and uses thereof

 #33
20200255814
2020-08-13

PH20 polypeptide variants, formulations and uses thereof

 #34
20170304389
2017-10-26

Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan Sulfate Mediated Macropinocytosis

 #35
20160362670
2016-12-15

PH20 polypeptide variants, formulations and uses thereof

 #36
20160341728
2016-11-24

BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

 #37
20160281165
2016-09-29

METHODS FOR DIAGNOSING, SCREENING, IDENTIFYING, MONITORING, AND TREATING ADVERSE LOCAL TISSUE REACTIONS, WHICH LEAD TO FAILURE OF ORTHOPEDIC IMPLANTS

 #38
20160022759
2016-01-28

Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis

 #39
20150184219
2015-07-02

Enzyme assays on a droplet actuator

 #40
20140322734
2014-10-30

Biomarkers for prediction, diagnosis, and monitoring of parkinson's disease

 #41
20140178330
2014-06-26

PH20 polypeptide variants, formulations and uses thereof

 #42
20140066464
2014-03-06

Methods of diagnosing and treating cancer

 #43
20130302275
2013-11-14

PH20 polypeptide variants, formulations and uses thereof

 #44
20120136147
2012-05-31

Method of hydrolyzing an enzymatic substrate

 #45
20120115165
2012-05-10

BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

 #46
20110059474
2011-03-10

Method for determining carbohydrate and kit for determining carbohydrate

 #47
20100184109
2010-07-22

Acquisition method for biological rhythm information

 #48
20100129832
2010-05-27

Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes

 #49
20100108611
2010-05-06

Assay and kit and device for removing amylase from body fluids

 #50
20090325201
2009-12-31

Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma

 #51
18778554
2025-04-01

PH20 polypeptide variants, formulations and uses thereof